Exhibit 31.1
 CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO RULE 13a-14(a) OR 15d-14(a)
OF THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
  1.
    
    I have reviewed this quarterly report on Form 10-Q of Liberator
Medical Holdings, Inc. and Subsidiaries (the Registrant);2.
    
    Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the
circumstances under which such statements were made, not
misleading with respect to the period covered by this report;3.
    
    Based on my knowledge, the unaudited condensed consolidated
financial statements, and other financial information included in
this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this
report;4.
    
    The Registrants other certifying officer and I are
responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
Registrant and have:
 a)
    
    Designed such disclosure controls and procedures, or
caused such disclosure controls and procedures to be
designed under our supervision, to ensure that
material information relating to the Registrant, including its consolidated subsidiaries, is
made known to us by others within those entities,
particularly during the period in which this report
is being prepared;b)
    
    Designed such internal control over financial
reporting, or caused such internal control over
financial reporting to be designed under our
supervision, to provide reasonable assurance
regarding the reliability of financial reporting and
the preparation of financial statements for external
purposes in accordance with generally accepted
accounting principles;c)
    
    Evaluated the effectiveness of the Registrants disclosure controls and procedures and
presented in this report our conclusions about the
effectiveness of the disclosure controls and
procedures, as of the end of the period covered by
this report based on such evaluation;d)
    
    Disclosed in this report any change in the Registrants internal control over financial
reporting that occurred during the Registrants most recent fiscal quarter that has
materially affected, or is reasonably likely to
materially affect, the Registrants
internal control over financial reporting; and
 5.
    
    The Registrants other certifying officer and I have
disclosed, based on our most recent evaluation of internal control
over financial reporting, to the Registrants auditors
and the audit committee of Registrants board of
directors (or persons performing the equivalent functions):
 a)
    
    All significant deficiencies and material weaknesses
in the design or operation of internal control over
financial reporting which are reasonably likely to
adversely affect the Registrants ability
to record, process, summarize and report financial
information; andb)
    
    Any fraud, whether or not material, that involves
management or other employees who have a significant
role in the Registrants internal control
over financial reporting.
 Dated: February 6, 2009
    /s/ Mark A. LibratoreMark A. Libratore,President and Chief Executive Officer